» Articles » PMID: 32017047

Conditional Survival After Neoadjuvant Chemoradiotherapy and Surgery for Oesophageal Cancer

Overview
Journal Br J Surg
Specialty General Surgery
Date 2020 Feb 5
PMID 32017047
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conditional survival accounts for the time already survived after surgery and may be of additional informative value. The aim was to assess conditional survival in patients with oesophageal cancer and to create a nomogram predicting the conditional probability of survival after oesophagectomy.

Methods: This retrospective study included consecutive patients with oesophageal cancer who received neoadjuvant chemoradiation followed by oesophagectomy between January 2004 and 2019. Conditional survival was defined as the probability of surviving y years after already surviving for x years. The formula used for conditional survival (CS) was: CS  = S /S , where S represents overall survival at x years. Cox proportional hazards models were used to evaluate predictors of overall survival. A nomogram was constructed to predict 5-year survival directly after surgery and given survival for 1, 2, 3 and 4 years after surgery.

Results: Some 660 patients were included. Median overall survival was 44·4 (95 per cent c.i. 37·0 to 51·8) months. The probability of achieving 5-year overall survival after resection increased from 45 per cent directly after surgery to 54, 65, 79 and 88 per cent given 1, 2, 3 and 4 years already survived respectively. Cardiac co-morbidity, cN category, ypT category, ypN category, chyle leakage and pulmonary complications were independent predictors of survival. The nomogram predicted 5-year survival using these predictors and number of years already survived.

Conclusion: The probability of achieving 5-year overall survival after oesophagectomy for cancer increases with each additional year survived. The proposed nomogram predicts survival in patients after oesophagectomy, taking the years already survived into account.

Citing Articles

Dynamic assessment of long-term survival in survivors with stage III non-small cell lung cancer: a novel conditional survival model with a web-based calculator.

Meng X, Wang P, Liu J, Sun D, Ju Z, Cai Y Front Med (Lausanne). 2025; 11():1491337.

PMID: 39839626 PMC: 11746034. DOI: 10.3389/fmed.2024.1491337.


Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.

Liang X, Su Y, Li X, Fu Y, Ma R, Yang R Ann Surg Oncol. 2024; 32(4):2912-2922.

PMID: 39538101 DOI: 10.1245/s10434-024-16485-1.


Conditional survival and changing risk profile in patients with gliosarcoma.

Xu L, Yang Z, Chen H, Sun C, Tu C, Gu Z Front Med (Lausanne). 2024; 11:1443157.

PMID: 39309681 PMC: 11412853. DOI: 10.3389/fmed.2024.1443157.


The conditional recurrence-free survival after R0 hepatectomy for locally advanced intrahepatic cholangiocarcinoma: A competing risk analysis based on inflammation-nutritional status.

Huang G, Xi P, Yao Z, Zhao C, Li X, Lin X Heliyon. 2024; 10(13):e33931.

PMID: 39055818 PMC: 11269833. DOI: 10.1016/j.heliyon.2024.e33931.


Individualized prediction of conditional survival for colorectal signet-ring cell carcinoma patients.

Gu J, Zhang L, Zhang Y, Chen X, Gu T, Cai J Ann Med Surg (Lond). 2024; 86(5):2524-2530.

PMID: 38694354 PMC: 11060288. DOI: 10.1097/MS9.0000000000001982.


References
1.
van den Boorn H, Abu-Hanna A, Ter Veer E, van Kleef J, Lordick F, Stahl M . SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer. Cancers (Basel). 2019; 11(2). PMC: 6406639. DOI: 10.3390/cancers11020187. View

2.
Mayo S, Nathan H, Cameron J, Olino K, Edil B, Herman J . Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2011; 118(10):2674-81. PMC: 3578343. DOI: 10.1002/cncr.26553. View

3.
Collins G, Reitsma J, Altman D, Moons K . Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement. Eur Urol. 2015; 67(6):1142-1151. DOI: 10.1016/j.eururo.2014.11.025. View

4.
Bailey S, Bull D, Harpole D, Rentz J, Neumayer L, Pappas T . Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg. 2003; 75(1):217-22; discussion 222. DOI: 10.1016/s0003-4975(02)04368-0. View

5.
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View